Manufacturer/Brand : Glenmark Pharmaceuticals Ltd
Salt Composition : Remogliflozin Etabonate (100Mg) + Vildagliptin (50Mg)
Description : Remo-V Tablet is a combination of two medicines used in the treatment of type 2 diabetes mellitus. It is approved for use in adults aged 18 years and older to improve glycemic control. It is generally used when other diabetes medicines do not provide adequate glycemic control.
Uses :• Type 2 diabetes mellitus